Intelligent Bio Solutions Files 8-K
Ticker: INBS · Form: 8-K · Filed: Sep 17, 2025 · CIK: 1725430
Sentiment: neutral
Topics: sec-filing, 8-K, corporate-update
TL;DR
IBSI filed an 8-K on 9/17/25. Check for updates.
AI Summary
Intelligent Bio Solutions Inc. filed an 8-K on September 17, 2025, reporting other events and financial statements. The company, formerly known as GBS Inc., is incorporated in Delaware and has its principal executive offices in New York City.
Why It Matters
This filing indicates that Intelligent Bio Solutions Inc. has made a regulatory submission to the SEC, which may contain important updates on the company's operations or financial status.
Risk Assessment
Risk Level: low — This is a routine SEC filing (8-K) that typically reports significant events or financial updates, but does not inherently signal high risk without further context.
Key Players & Entities
- INTELLIGENT BIO SOLUTIONS INC. (company) — Registrant
- GBS Inc. (company) — Former company name
- Glucose Biosensor Systems (Greater China) Holdings, Inc. (company) — Former company name
- September 17, 2025 (date) — Date of Report
FAQ
What specific events are being reported in this 8-K filing?
The filing indicates 'Other Events' and 'Financial Statements and Exhibits' as items of information, but the specific details of these events are not provided in the provided text.
When was the company formerly known as GBS Inc.?
The company's name was changed from GBS Inc. on September 19, 2019.
What is the principal executive office address for Intelligent Bio Solutions Inc.?
The principal executive offices are located at 135 West 41st Street, 5th Floor, New York, NY 10036.
What is the company's fiscal year end?
The company's fiscal year ends on June 30.
What is the SIC code for Intelligent Bio Solutions Inc.?
The Standard Industrial Classification (SIC) code is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Filing Stats: 506 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2025-09-17 08:48:54
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value INBS The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 36KB
- ex99-1.htm (EX-99.1) — 11KB
- 0001493152-25-013836.txt ( ) — 216KB
- inbs-20250917.xsd (EX-101.SCH) — 3KB
- inbs-20250917_lab.xml (EX-101.LAB) — 33KB
- inbs-20250917_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 17, 2025 INTELLIGENT BIO SOLUTIONS INC. By: /s/ Spiro Sakiris Name: Spiro Sakiris Title: Chief Financial Officer